| Part Of FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine
Report Video IssueFDA Open Meeting on Moderna COVID-19 Vaccine, Part 2
2020-12-17T14:03:35-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvODQ0XC8yMDIwMTIxNzE0MDQwNTAwM19oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==The Food and Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should be recommended for emergency use authorization. Members of the Vaccines and Related Biological Products Advisory Committee heard public comments and testimony from Moderna on its vaccine. During this final portion of the meeting, the committee continued their discussion before voting on whether the benefits of the COVID-19 vaccine outweigh the risks for use on individuals 18 years of age or older. After voting by computer, the result was “a favorable vote,” with most of the members voting for use of the vaccine.
The Food and Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should be recommended for … read more
The Food and Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should be recommended for emergency use authorization. Members of the Vaccines and Related Biological Products Advisory Committee heard public comments and testimony from Moderna on its vaccine. During this final portion of the meeting, the committee continued their discussion before voting on whether the benefits of the COVID-19 vaccine outweigh the risks for use on individuals 18 years of age or older. After voting by computer, the result was “a favorable vote,” with most of the members voting for use of the vaccine. close
People in this video
- Paula Annunziato Associate Vice President Merck Research Laboratories
- Prabhakara Atreya Director U.S. Food and Drug Administration->Scientific Advisers and Consultants
- Juan Banacloche Specialist Mayo Clinic->Infectious Diseases
- Archana Chatterjee Senior Associate Dean University of South Dakota->Medical School
- Amanda Cohn Executive Secretary Advisory Committee on Immunization Practices
- Doran Fink Deputy Director U.S. Food and Drug Administration->Vaccines and Related Biological Products Advisory Committee
- Oveta Fuller Professor University of Michigan Medical School
- Hayley Gans Professor Stanford University->Pediatric Infectious Diseases
- Steven Goodman Professor Stanford University->Epidemiology and Health
- Mike Kaczynski Project Manager U.S. Food and Drug Administration
- David Kim Director Centers for Disease Control and Prevention->Immunization Division
- Jeannette Lee Professor University of Arkansas->Biostatistics
- Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
- Peter W. Marks M.D. Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
- Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
- Jacqueline Miller M.D. Senior Vice President Moderna->Infectious Disease Therapeutics
- Patrick Moore Professor University of Pittsburgh->Cancer Institute
- James Neaton Professor University of Minnesota->Biostatistics
- Paul Offit M.D. Chief Children's Hospital of Philadelphia->Division of Infectious Diseases
- Steven Pergam Professor Fred Hutchinson Cancer Research Center
- Stanley Perlman M.D. Professor University of Iowa->Immunology
- Eric Rubin M.D. Editor in Chief New England Journal of Medicine
- Robert Schooley M.D. Professor University of California, San Diego->School of Medicine
- Gregg Sylvester M.D. Chief Medical Officer Seqirus->Medical Affairs
- Sheldon Toubman Assistant Attorney New Haven Legal Assistance
- Ralph Tripp Associate Professor University of Georgia->Veterinary Infectious Diseases
- Melinda Wharton Director Centers for Disease Control and Prevention->Immunization Division
- Tal Zaks M.D. Chief Medical Officer Moderna
- Rachel Zhang Medical Officer U.S. Food and Drug Administration
-
-
-
-
-
-
Hosting Organization
More Videos From
FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine
Purchase a Download
FDA Open Meeting on Moderna COVID-19 Vaccine, Part 2
-
MP3 audio - Standard
- Price:
- $0.99
Featured Clips from This Video
-
FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine
The FDA Advisory Committee has voted favorably to recommend the Moderna COVID-19 vaccine for people 18 or older. The vot…
- 1 minute
- 91 views
Related Video
-
Food and Drug Administration Open Meeting on Moderna COVID-19 Vaccine, Part 1
The FDA held a day-long meeting on Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine. Presentations from …
-
FDA Meeting on COVID-19 Vaccine and Emergency Use Authorization, Part 1
The Food and Drug Administration hosted a virtual open meeting to discuss Pfizer-BioNTech COVID-19 vaccine and Emergency…
-
FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 1
The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnso…
-
FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 2
The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnso…
User Created Clips from This Video
-
- 1 minute
- 91 views
-
- 2 minutes
- 8 views